By: Ira EpsteinLow $1,260's support on gold...Read More
Sometimes we're blessed not to possess insider information. Several pointed examples surfaced in the last few days. If we had known, for instance, that Fed Chairman Powell would tell the world on Wednesday that the U.S. economy is holding steady as a rock and that no changes are contemplated in monetary policy, we'd have jumped on call options a day earlier. Lo, the Dow began a 500-point plunge...Read More
The unemployment rate fell to a 49-year lowAll three stock market indexes managed big wins today, thanks to better-than-expected April jobs data. Specifically, the U.S. created 263,000 jobs last month, while the unemployment rate fell to a 49-year low of 3.6%. In addition, the Nasdaq got a boost from Amazon (AMZN), on news that Warren Buffett's Berkshire Hathaway is amassing a stake. Against this...Read More
The best part? It's risk-free. In an explosive report a former Lehman Brothers executive reveals one of Wall Street's most closely guarded investing secrets.The secret?A proven system for turning small sums of cash into vast windfalls of profits-without risking a penny in the stock market.Essentially, this system uses the latest advances in computer science and financial technology to give inve...Read More
Traders also digested better-than-expected jobs data this weekThe week started off on a high note, with the Nasdaq Composite (IXIC) and S&P 500 Index (SPX) each touching a fresh record peak. The Dow Jones Industrial Average (DJI) also got a lift early in the week, thanks to a round of strong earnings from big-cap pharma stocks, with all three indexes marking a fourth straight monthly gain. However...Read More
The shares remain well below their late-February IPO price, tooThe U.S. equities market is heading for a daily win, though the Dow still seems poised for its second straight weekly loss. Among individual stocks making notable moves today are e-sports name Super League Gaming Inc (NASDAQ:SLGG), implantable eye lens specialist STAAR Surgical Company (NASDAQ:STAA), and space technology firm Maxar Tec...Read More
Gold futures climbed Friday, recouping some of the sharp loss from a day earlier that sent prices to their lowest level of the year, but the precious metal still registered a loss for the week-their fifth in six weeks. Data Friday revealed that the U.S. created a larger-than-expected 263,000 new jobs in April, which helped the unemployment rate fall to a 49-year low of 3.6%. In reaction, however,...Read More
Gold futures climbed Friday, recouping some of the sharp loss from a day earlier that sent prices to their lowest level of the year, but the precious metal still registered a loss for the week-their fifth in six weeks. Data Friday revealed that the U.S. created a larger-than-expected 263,000 new jobs in April, which helped the unemployment rate fall to a 49-year low of 3.6%. In reaction, however,...Read More
The analyst's new price target represents expected upside of 51%Ahead of earnings next Tuesday, May 7, Oppenheimer initiated coverage of Allogene Therapeutics Inc (NASDAQ:ALLO) with an "outperform" rating. In addition, the brokerage firm set a lofty price target of $45 -- a 51% premium to Thursday's close. The brokerage firm waxed optimistic on Allogene's off-the-shelf CAR-Ts prospects and its al...Read More
The biopharma stock is selling off on Sanofi newsAmid an up day in the broader equities market, the shares of Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY) are trading 6.4% lower at $77.25, on news Sanofi (SNY) divested its roughly 10% stake in the biopharmaceutical firm. This comes after the two companies concluded a research and options phase of an RNAi therapeutics collaboration that began in 201...Read More
A new report by GlobalData shows the value of deals in the metals and mining sector jumped from last year, despite the number of agreements inked falling.The independent analytics firm's data shows overall deal value in Q1 2019 grew by 6.3% to $22.5B from $21.2B in the same period last year. Deal volume decreased by 8.7% from 358 in Q1 2018 to 327 deals in Q1 2019.CIBC tops the list, with the Cana...Read More
The shares are up almost 37% year-to-dateNvidia Corporation (NASDAQ:NVDA) stock has had an impressive start to 2019, up nearly 37% so far. The shares recently pulled back after running into familiar resistance in the $190 region, but history suggests NVDA stock could make another run higher over the next few weeks.Specifically, the equity is trading within one standard deviation of its 40-day movi...Read More
Large scale gold mining in sub-Saharan Africa has reduced infant mortality in nearby communities, with rates falling by 50% among those born within 10km of a gold mine, conclusion new research by Anja Benshaul-Tolonen published in the May 2019 issue of The Economic Journal. Benshaul-Tolonen's research finds that local industrial development may be an effective way to reduce infant mortality in...Read More
Uber stock is set to start trading on May 10Next week is a monumental one for LYFT Inc (NASDAQ:LYFT). First, the ride-sharing service has its first earnings report as a public company, scheduled for after the close on Tuesday, May 7. Then, fierce rival in the ride-sharing sector Uber (UBER) will go public a week from today. At last check, Lyft stock is down 1.2% to trade at $60.70, after Atlant...Read More
Tech's performance has the Nasdaq rallyingStocks are holding positive territory in midday trading following this morning's impressive jobs report. In fact, the Dow Jones Industrial Average (DJI), S&P 500 Index (SPX), and Nasdaq Composite (IXIC) are all comfortably higher. While the tech sector is leading the way, energy stocks are also showing strength. However, the major indexes would need to ext...Read More
H.C. Wainwright just started with a "buy" rating and a $23 price targetH.C. Wainwright just initiated coverage on the drugmaker Collegium Pharmaceutical, Inc (NASDAQ:COLL) with a "buy" rating and a $23 price target -- a roughly 60% upside to the stock's current perch at $13.60. The analyst called the firm, which specializes in abuse-deterrent pain treatments, an "undervalued growth story," especia...Read More
Cognizant Technology option bears are cashing in their chipsThe shares of tech concern Cognizant Technology Solutions Corp (NASDAQ:CTSH) are spiraling in early trading, after the firm announced first-quarter earnings below analysts' expectations. The company also nearly halved its full-year sales forecast. As a result, CTSH stock is down 10.2% at $59.82 in early trading, pacing for its worst day s...Read More
Sweden's Boliden on Friday reported first-quarter core earnings slightly above analysts forecasts, and said production in the quarter had been stable both in its mines and its smelters.Operating profit, excluding revaluation of process inventory, fell to 2.05 billion Swedish crowns from 2.72 billion a year earlier, beating the 1.99 billion seen by analysts in a Reuters poll."The period can be summ...Read More
CI has shed 16.3% since JanuaryHealth insurance name Cigna Corp (NYSE:CI) is down 0.8% at $159 in this morning's trading, suffering after Goldman Sachs downgraded the stock to "buy" from "conviction buy." The firm's Stephen Tanal shared similar concerns of analysts that responded to the company's first-quarter report yesterday, expressing worry over Cigna's pharmacy benefits profitability followi...Read More
The shares of the two tech giants are higher as a resultFAANG name Amazon.com, Inc. (NASDAQ:AMZN) is in the news today, after Warren Buffett told CNBC that Berkshire Hathaway (BRK.A) bought an undisclosed stake in the online retail giant. The details of the purchase will be revealed in Berkshire's quarterly report of stock holdings.In response, Amazon stock is up 2.1% to trade at $1,940.95. Yeste...Read More